Sortase anchored proteins of Streptococcus uberis play major roles in the pathogenesis of bovine mastitis in dairy cattle by Leigh, James A. et al.
Original article
Sortase anchored proteins of Streptococcus uberis
play major roles in the pathogenesis of bovine mastitis
in dairy cattle
James A. LEIGH
1*, Sharon A. EGAN
1, Philip N. WARD
2, Terence R. FIELD
3,
Tracey J. COFFEY
3
1 The School of Veterinary Medicine and Science, The University of Nottingham, Sutton Bonington Campus,
Sutton Bonington, Leicestershire, LE12 5RD, United Kindgom
2 Nufﬁeld Department of Clinical Laboratory Sciences, Oxford University, John Radcliffe Hospital, Headington,
OX3 9DU, United Kingdom
3 Institute for Animal Health, Compton, Berkshire, RG20 7NN, United Kingdom
(Received 16 March 2010; accepted 2 June 2010)
Abstract – Streptococcus uberis, strain 0140J, contains a single copy sortase A (srtA), encoding a
transamidase capable of covalently anchoring speciﬁc proteins to peptidoglycan. Unlike the wild-type, an
isogenic mutant carrying an inactivating ISS1 insertion within srtA was only able to infect the bovine
mammary gland in a transient fashion. For the ﬁrst 24 h post challenge, the srtA mutant colonised at a
similar rate and number to the wild type strain, but unlike the wild type did not subsequently colonise in
higher numbers. Similar levels of host cell inﬁltration were detected in response to infection with both
strains, but only in those mammary quarters infected with the wild type strain were clinical signs of disease
evident. Mutants that failed to express individual sortase substrate proteins (sub0135, sub0145, sub0207,
sub0241, sub0826, sub0888, sub1095, sub1154, sub1370, and sub1730) were isolated and their virulence
determined in the same challenge model. This revealed that mutants lacking sub0145, sub1095 and sub1154
were attenuated in cattle. These data demonstrate that a number of sortase anchored proteins each play a
distinct, non-redundant and important role in pathogenesis of S. uberis infection within the lactating bovine
mammary gland.
mastitis / S. uberis / virulence / sortase / vaccine
1. INTRODUCTION
Streptococcus uberis is one of the most com-
mon pathogens isolated from cases of bovine
mastitis [7]. It impacts negatively on animal
health, welfare and the economics of milk pro-
duction. S. uberis has been shown in experi-
mental infection models within the dairy cow
to colonise the mammary gland rapidly, induce
neutrophil diapedesis and cause an acute local
inﬂammation during which milk becomes dena-
tured and the mammary gland distended, swol-
len and painful. S. uberis persists within the
mammary gland in the presence of neutrophils
and other host defences, which seem to offer lit-
tle control. However, the infection remains
localised to the mammary gland and the bacte-
rium is found largely in the secretion present
within the lumen of the gland. Although a
common mammary pathogen, S. uberis is
often found as part of the normal, commensal
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monly associated with other disease states.
The interaction of S. uberis with its immedi-
ate environment in the host is likely to be
dependent on components that are at the bacte-
rial surface or are released into the surrounding
medium during the infection process. The sur-
face of Gram-positive bacteria is decorated with
many different macromolecules, including car-
bohydrates, teichoic acids, polysaccharides
and proteins. In many species a subset of sur-
face proteins have been reported to be cova-
lently linked to the peptidoglycan matrix of
t h ec e l lw a l l[ 22, 30, 39]. In almost all studies
to date, covalent attachment of proteins relies
on the transamidase, sortase [12]. This activity
was ﬁrst described in Staphylococcus aureus
[27] and since then ﬁve different classes of sor-
tase enzyme have been identiﬁed in Gram posi-
tive bacteria [13, 33].
Proteins destined for surface location in
Gram-positive bacteria are targeted for transport
across the cytoplasmic membrane due to the
presence of a hydrophobic N-terminal signal
peptide. Following transport through the mem-
brane and removal of the signal peptide, the
polypeptide is cleaved within a speciﬁc sorting
motif located towards the C-terminus of the
protein. Sortase subsequently reforms an amide
bond between the carboxyl group of the new
C-terminal amino acid and the amino group
of peptides that cross bridge the peptidoglycan
of the cell wall. In the absence of sortase, pro-
teins are not anchored and may be released into
the surrounding medium with their C-termini
intact [25, 46].
Each class of sortase has been reported to
anchor a speciﬁc and discrete subset of proteins
by recognition of a speciﬁc amino acid
sequence motif contained within the substrate
protein. A recent investigation in S. uberis
revealed two sequences (LPXXG and
LPXXXD) that appear to function as cell wall
attachment motifs in this and other streptococci
[14].
The published sequence of S. uberis [44]
contains a single coding sequence (sub0881)
with homology to sortase (SrtA) and
10 CDS (sub0135, sub0145, sub0207,
sub0241, sub0826, sub0888, sub1095, sub1154
and sub1370, sub1730) containing the LPXXG
or LPXXXD motifs along with other features
typically required for cell wall anchoring [14].
Of these, the presence of nine was conﬁrmed
by comparative proteomic analysis of the wild
typeandSrtAmutant[14].Thesortaseanchored
proteins identiﬁed in S. uberis include a number
of putative virulence determinants identiﬁed in
other streptococci [14, 44].
In this communication, we report the ability
of S. uberis to infect the bovine mammary
gland and induce mastitis in the absence of SrtA
or individual SrtA-anchored proteins.
2. MATERIALS AND METHODS
2.1. Bacterial strains and reagents
S. uberis strain 0140J and an isogenic insertional
mutant lacking SrtA, as described previously [14]
were used throughout this study. Bacterial cultures
were routinely grown in Todd Hewitt broth and pla-
ted on sheep blood agar containing 1% (w/v) aesculin
(ABA). Other bacterial strains and reagents were
used as described in the text. Oligonucleotide primers
for PCR ampliﬁcation are referred to in the text by
their speciﬁc reference numbers (PXXX) and the
sequence of each is shown in Table I.
2.2. Production and isolation of mutant strains
of S. uberis
Insertionally inactivated mutants were located
within a random insertional mutant bank of S. uberis
strain 0140J by PCR as previously described [43].
Primers speciﬁc for each locus of interest were used
in conjunction with those speciﬁc to ISS1 (Tab. I).
Attempts to isolate an insertion mutant with ISS1
located near to the start of the sub1154 coding
sequence proved unsuccessful. Subsequently, a tar-
geted deletion strategy was used to ablate production
of the sub1154 gene product. Brieﬂy, two fragments
located at either end of the 3.4 kb open reading frame
were ampliﬁed from genomic DNA using primer
pairs P689/P690 and P691/P692 (Tab. I). The two
fragments were puriﬁed and used in equal proportion
as template in a further ampliﬁcation reaction with
primers P689 and P692 to generate a single D1154
product lacking 3169 bp of the sub1154 coding
sequence. This amplicon was subcloned into the mul-
tiple cloning site of the low copy pG
+h9 temperature
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during ampliﬁcation with P689 and P692. The plas-
mid construct was transformed into E. coli TG1
RepA and transformants cultured on LB agar/broth
(200 lg/lL erythromycin) at 37.5  C. The re-iso-
lated puriﬁed plasmid (10 ng) was used to transform
S. uberis 0140J and transformants selected on THA
(1 lg/mL erythromycin) at 28  C. S. uberis
0140J / pG
+h9::D1154 transformants were grown to
OD550nm 0 . 5i nT o d dH e w i t tb r o t ha t2 8 C, the
growth temperature was then raised to 37.5  C
to force single cross-over chromosomal integration.
Integrant colonies were selected on THA ery (1 lg/
mL) at 37  C and subsequently grown in THB lack-
ing antibiotic at 28  C to promote excision of the
pG
+h9 replicon by a second cross-over event. Result-
ing erythromycin sensitive colonies were picked from
THA plates, grown overnight at 37  C and deletion
of the sub1154 locus was determined by PCR ampli-
ﬁcation. Southern analysis and DNA sequencing
were employed to conﬁrm the exact nature of the
deletion.
2.3. Extraction of chromosomal
DNA from S. uberis
Genomic DNA was prepared using a variation of
the method of Hill and Leigh as described previously
[19]. Brieﬂy, 1.5 mL of an overnight culture was cen-
trifuged at 10 000 · g for 2 min and the cell pellet
washed with 500 lLo f1 0 m MT r i s - C l ,5 m M
EDTA, pH 7.8. Bacterial cell walls were disrupted
by resuspension in 375 lLo f1 0 m MT r i s - C l ,
5 mM EDTA pH 7.8 containing 30 units/mL mutan-
olysin and 10 mg/mL lysozyme (both from Sigma,
Poole, UK) and subsequent incubation at 37  Cf o r
30 min. Total cell lysis was achieved by addition of
20 lL of SDS solution (20% w/v in 50 mM Tris-
Cl, 20 mM EDTA, pH 7.8) and proteinase K (Sigma)
to a ﬁnal concentration of 150 lg/mL and a further
incubation at 37  C for 1 h. Cell wall material was
removed by precipitation following the addition of
200 lL of saturated NaCl and subsequent centrifuga-
tion at 12 000 · g for 10 min. The supernatant was
extracted with phenol chloroform and DNA precipi-
tated by addition of 2 volumes of absolute ethanol.
DNA pellets were washed with 70% aqueous ethanol
a n da i r - d r i e dp r i o rt or e s u s p e n s i o ni nT Eb u f f e rc o n -
taining 20 lg/mL RNaseA (Sigma).
2.4. Challenge of lactating dairy cows
with S. uberis
The requirement by S. uberis strain 0140J for
SrtA and/or individual SrtA-substrates (Tab. III)f o r
virulence was determined by experimental challenge
in a well established intramammary infection model
in the dairy cow. Bacteria were grown for 18 h at
37  C in Todd Hewitt broth. Cells were recovered
by centrifugation (10 000 · g, 10 min), suspended
in pyrogen-free saline (Sigma) and diluted in the
same to the appropriate cell density. Suspensions of
each strain were held on ice prior to being used to
challenge animals. The actual number of viable bac-
teria in identical aliquots of each suspension was enu-
m e r a t e db o t hp r i o rt oa n df o l l o w i n gc h a l l e n g e .
Dairy cows (Holstein, Friesian), 2–10 weeks into
their ﬁrst lactation, were selected for challenge. Crite-
ria for selection were: absence of signs of mastitis,
absence of bacteria in milk samples taken 24–48 h
prior to challenge, no history of mastitis during the
current lactation and no evidence of intramammary
i n f e c t i o ni nm i l ks a m p l e st a k e na t7a n d1 4d a y sa f t e r
parturition. Animals were challenged in mammary
quarters after milking by infusion of 1 mL of pyro-
gen-free saline (Sigma) containing S. uberis.
To determine the role of SrtA, two animals were
challenged in a total of four quarters with
Table II. Manifestation of clinical response to infection with Streptococcus uberis. All quarters and milk
samples were analyzed against these criteria at each milking following challenge.
Score Appearance of quarter Score Appearance of milk
1 Normal 1 Normal
2 Minor changes
(e.g. hardness)
2 Minor changes
(e.g. a few ﬂakes)
3 Moderate signs
(e.g. heat, tenderness)
3 Moderate signs
(e.g. clots and/or clumps)
4 Severe signs
(e.g. distended and discomfort on palpation)
4 Severe signs
(e.g. changes in colour and/or composition)
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2 cfu of strain 0140J and a further four ani-
mals, were challenged in a total of eight quarters with
as i m i l a rd o s eo ft h esrtA mutant. To subsequently
determine the requirement for individual SrtA-
anchored proteins, mutants lacking each protein were
used to challenge two mammary quarters on the same
animal with between 5.0 · 10
2–1.5 · 10
3 cfu. Any
mutant that failed to induce overt signs of mastitis
and that failed to colonise to high levels was subse-
quently rescreened in a similar challenge of a further
two mammary quarters in another dairy cow.
Following challenge, animals were milked and
inspected twice daily (07:00 h and 15:30 h) and
those in which predetermined criteria (Tab. II)f o r
clinical end points (clotted and discoloured milk
and/or udder quarter swollen or causing discomfort
on palpation) had been reached were treated with pro-
prietary branded antibiotics. Milk samples were taken
at each milking and analysed for bacteria and somatic
cells, as described below.
2.5. Analysis of milk samples
T h en u m b e ro fv i a b l eb a c t e r i ap r e s e n tw a se s t i -
mated by direct plating of up to 1 mL of each milk
sample on to ABA. Samples were also diluted in sal-
ine and 50 lL of each dilution plated directly onto
ABA. In each case, the presence and/or number of
S. uberis was determined and the genotype of the
recovered isolates was determined by PCR ampliﬁca-
tion of the altered locus. The number of somatic
cells present in milk samples was determined using
a DeLaval portable cell counter in line with the man-
ufacturer’s instructions.
2.6. Generation of recombinant SrtAD65 protein
A clone expressing a truncated version of the
recombinant sortase protein (SrtAD65) was generated
by PCR ampliﬁcation from S. uberis 0140J template
DNA using the sense primer p633 (located 195 bp
after the srtA gene (SUB0881) start codon) and the
antisense primer p628 (located 174 bp downstream
of srtA gene stop codon), incorporating a KpnIs i t e
for cloning into the pQE-1 expression plasmid
(Qiagen, Hilden, Germany). The 738 bp fragment
was generated using Phusion
TM high ﬁdelity polymer-
ase (New England Biolabs, Ipswich, USA), puriﬁed
using a MinElute PCR Puriﬁcation Kit (Qiagen)
a n dd i g e s t e dw i t hKpnI (New England Biolabs).
Fragments were cloned into pQE1 vector pre-treated
with PvuII, KpnI and Antarctic phosphatase (all New
England Biolabs) using T4 DNA Ligase (New
England Biolabs) at 14  C according to the manufac-
turer’s instructions. Twenty microlitres of the ligation
mixture was desalted [2] and approximately 10 ng of
the desalted ligation mixture was transformed
into Escherichia coli M15 pREP4 (Qiagen).
Table III. Sortase-anchored gene products identiﬁed by bioinformatic and proteomic analysis and
description of their mutation in S. uberis 0140J.
Gene/
Product
a
Protein
accession
number
b
Mutation ISS1
orientation
relative to
disrupted CDS
Location of
ISS1 insertion/
deletion
from ATG start codon
Predicted
translation of
disrupted mature
protein (%)
sub0135 YP_002561505 Insertion Forward 389 bp 10
sub0145 YP_002561515 Insertion Reverse 485 bp 24
sub0207 YP_002561573 Insertion Forward 682 bp 42
sub0241 YP_002561606 Insertion Forward 896 bp 34
sub0826 YP_002562161 Insertion Reverse 664 bp 13
sub0888 YP_002562216 Insertion Forward 205 bp 12
sub1095 YP_002562412 Insertion Reverse 312 bp 14
sub1154 YP_002562469 Deletion Disruption
extends from 118 bp
0.6
sub1370 YP_002562668 Insertion Forward 280 bp 5
sub1730 YP_002563003 Insertion Reverse 423 bp 32
a Gene annotation according to the genomic sequence of S. uberis 0140J [40].
b Protein accession number according to NCBI protein database.
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taining 50 lg/mL ampicillin (Amp) and 25 lg/mL
kanamycin (Kan). Recombinant (6 · His-tagged)
SrtAD65 protein was generated from overnight cul-
tures inoculated at a 1/50 dilution into LB broth con-
taining 50 lg/mL of Amp and 25 lg/mL of Kan.
Cultures were grown at 37  C with aeration (shaking
at 200 rpm) and protein expression induced, once
cultures reached an OD600nm of 0.8, by addition of
0.2 mM IPTG. Following further incubation
(2.5 h), cells were harvested by centrifugation
(16 000 · g, 10 min) and the bacterial pellets lysed
using CelLytic in the presence of 2 l/mL RNase,
2 l/mL DNase (all from Sigma) and Complete-
EDTA-free protease inhibitors (Roche, Mannheim,
Germany). Approximately 3 mg of soluble SrtAD65
recombinant protein was puriﬁed using HIS-Select
Cartridges (Sigma) and dialysed overnight against
MilliQ water using Slide-A-Lyzer dialysis cassettes
(Pierce, Rockford, USA) according to the manufac-
turer’s instructions.
2.7. Preparation of cellular extracts of S. uberis
Overnight cultures (400 mL) of S. uberis 0140J
and SrtA mutant were grown in THB overnight
and bacteria were harvested by centrifugation
(16 000 · g, 10 min). Complete protease inhibitors
(Roche) were added to all cellular extracts at a 1·
concentration. The bacterial growth medium was ﬁl-
ter sterilised through a 0.22 lm ﬁlter (Millipore, Bed-
ford, USA) and concentrated approximately 100-fold
using Amicon centrifugal ﬁlter devices (Millipore)
with 10 kDa molecular weight cut off. To precipitate
proteins, 4 volumes of methanol and chloroform (3:1)
was added to 1 volume of concentrated bacterial
growth media. The preparation was vortexed and 2
volumes of MilliQ water were added prior to centri-
fugation (16 000 · g, 2 min). The upper phase was
carefully removed and discarded. Proteins were
precipitated with 3 volumes of methanol, and col-
lected by centrifugation (16 000 · g,2m i n ) .T h e
supernatant was discarded and the remaining pellet
air-dried before resuspension in SDS-PAGE-loading
buffer.
To isolate capsule extracts, bacterial pellets from
above were washed 3 times with 40 mL of PBS
and centrifuged (16 000 · g,1 0 m i n ,4  C), then
resuspended in 500 lL of PBS containing hyaluron-
idase (100 U/mL, Sigma). Cells were incubated for
2ha t3 7 C and the capsule extract (supernatant)
collected following centrifugation (8000 · g,5m i n ) .
To isolate cell wall fractions, acapsular cells from
the preparation above were washed 3 times with
40 mL of PBS and resuspended in 500 lLo f4 0 %
sucrose/PBS containing mutanolysin (100 U/mL,
Sigma). The cell wall extract (supernatant) was col-
lected following centrifugation (1 500 · g,1 5m i n ) .
The remaining pellet was washed 3 times with
1 mL of cell membrane buffer (100 mM NaCl,
100 mM Tris-Cl ph 7.5, 10 mM MgCl2) and cycled
through 3 periods of freeze thawing ( 20  Ct o
37  C) and the cytoplasmic contents (supernatant)
were harvested following centrifugation
(10 000 · g, 10 min). The resulting pellet was
washed 3 times in 1 mL of cell membrane buffer
and resuspended in 500 lL of cell membrane buffer
containing 1% v/v Triton X-100 and incubated at
37  C for 1 h. The cell membrane fraction (superna-
tant) was harvested following centrifugation
(10 000 · g, 10 min) and all extracts were stored
at  20  C.
2.8. Production of antiserum in rabbits
and immunoblotting
Five aliquots of approximately 50 lg of freeze
dried puriﬁed recombinant SrtAD65 was supplied to
Davids Biotechnologie GmbH (Regensburg,
Germany) for anti-serum production in rabbits.
Anti-serum (50 mL) was supplied ﬁlter sterilized
and containing 0.02% sodium azide as a preservative.
Cellular extracts were separated on 12% or 15%
sodium-dodecyl sulphate polyacrylamide (SDS-
PAGE) gels and were stained using InstantBlue
(Expedeon protein solutions, Cambridge, UK) or
transferred onto Amersham Hybond
TM-C Extra nitro-
cellulose membranes (GE Healthcare, Little Chalfont,
UK) for immuno-detection. Transfer was performed
at 170 mA for 1 h in a Transblot apparatus (Biorad,
Hemmel Hemstead, UK) in transfer buffer consisting
of 25 mM Tris-base, 192 mM glycine and 20% (v/v)
methanol, pH 8.1–8.4. Following transfer, mem-
branes were incubated in a solution of 1% (w/v) skim
milk (Marvel; Premier International Foods, UK) in
PBS at 4  C overnight. Membranes were washed
three times for 5 min in PBS containing 0.1% Tween
20 (PBST) then incubated with SrtA rabbit antiserum
at a 1:1 000 dilution in 1% (w/v) skim milk in PBS
for 1 h. Membranes were washed three times for
5 min in PBST then incubated with goat anti-rabbit
immunoglobulin G conjugated to HRP (Southern
Biotech, Alabama, USA) at a 1:1 000 dilution for
1 h. Membranes were washed again as above and
HRP conjugate was detected using a solution of
0.5 mg/mL 4-chloronaphthol in PBS containing
16.7% methanol and 0.00015% (v/v) of H2O2.T h e
reaction was incubated in the dark until coloured
S. uberis mastitis sortase anchored proteins Vet. Res. (2010) 41:63
(page number not for citation purpose) Page 7 of 16bands were visible. Subsequently, membranes were
washed in PBS, air-dried and stored in the dark.
3. RESULTS
3.1. Sub-cellular localisation of SrtA in S. uberis
A protein band of approximately 26 kDa
was detected in the cell membrane-enriched
fraction and to a lesser extent in the cytoplas-
mic-enriched fraction of the wild type by
immunoblotting with antiserum raised against
rSrtA (Fig. 1). The size of the detected protein
was consistent with that of the translated prod-
uct from sub0881 following the predicted N-ter-
minal cleavage [44]. No such protein was
detected in any of the sub-cellular fractions gen-
erated from the SrtA mutant (Fig. 1).
3.2. Infectivity and virulence of the wild-type
and SrtA mutant following experimental
challenge in the lactating bovine
mammary gland
All challenged quarters of animals that
received wild type S. uberis became infected
and shed bacteria at around 10
6 cfu/mL by
48–60 h post challenge (Fig. 2A). Following
challenge of eight quarters on four animals with
the SrtA mutant, all showed evidence of infec-
tion and the SrtA mutant was detected in milk
at levels similar to those for the wild type for
up to 24 h post challenge. However, subsequent
bacterial colonization declined, from a typical
level of 10
4 cfu/mL of milk by 24 h post chal-
lenge, such that by the end of the experiment
(7 days post challenge) the mean bacterial num-
ber present was around 10 cfu/mL (Fig. 2B).
By this time, only 3 of the 8 quarters continued
to shed bacteria the remainder having elimi-
nated the infection (< 1 cfu/mL milk).
The cellular inﬁltration into the mammary
gland in response to infection was identical in
both groups of animals and was not dependent
on the challenge strain. In each case, this was
similar to that reported previously in this model
and reached a maximum of between 10
6 and
10
7 cells/mL of milk by 48–60 h post
challenge. In animals challenged with the wild
type strain this coincided with the appearance
of acute clinical signs of mastitis (Tab. II;
Fig. 2C) which required administration of
antibiotic therapy to eliminate infection and to
alleviate signs of disease. In stark contrast,
animals that had received the SrtA mutant
showed only very minor, if any, signs of
mastitis (Tab. II; Fig. 2C).
3.3. Isolation of mutants lacking individual SrtA
anchored proteins
Mutants carrying lesions within each of the
genes encoding SrtA anchored protein were iso-
lated by genotypic selection from a random
mutant bank. Each mutant was cured of the
plasmid insertion and shown by Southern blot-
ting to contain one copy of the ISS1 element
(data not shown). In one case (sub1154) ISS1
insertion was not identiﬁed in sufﬁciently close
Figure 1. Cellular localisation of sortase A (SrtA)
in Streptococcus uberis. Protein extracts were
obtained from S. uberis 0140J and srtA mutant
from cultures grown overnight in THB media.
Fractions were separated on 15% SDS PAGE gels,
transferred to nitrocellulose and probed with anti-
serum to SrtA (size of proteins of known molecular
mass are indicated). Extracts were loaded as
follows: from S. uberis 0140J capsule (lane 1);
mutanolysin-derived cell wall (lane 3); cytoplasmic
(lane 5); cell membrane (lane 7) and precipitated
media extracts (lane 9) and from the srtA mutant
capsule (lane 2); mutanolysin-derived cell wall
(lane 4); cytoplasmic (lane 6); cell membrane
(lane 8) and precipitated media extracts (lane 10).
(A color version of this ﬁgure is available online at
www.vetres.org.)
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Page 8 of 16 (page number not for citation purpose)Figure 2. Bacterial isolation, somatic cell count and clinical response following challenge with S. uberis
0140J and SrtA mutant in dairy cattle. (A) Bacterial recovery of S. uberis following challenge. Data are
represented as the geometric means of the number of bacteria obtained from the milk of animals challenged
with either strain 0140J (n = 4) or the SrtA mutant (n = 8), as indicated on the ﬁgure. (B) Cellular
inﬂux at each milking following challenge. Data are represented by the geometric means of the
number of somatic cells obtained from the milk of animals challenged with either strain 0140J
(n = 4) or the SrtA mutant (n = 8), as indicated on the ﬁgure. (C) Combined clinical scores from
clinical manifestations following S. uberis challenge. Data are represented by the mean of clinical
scores given for the appearance of the quarter and appearance of the milk, as outlined in Table II
with either strain 0140J (n = 4) or the SrtA mutant (n = 8), as indicated on the ﬁgure.
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function and this gene was subsequently dis-
rupted by allelic exchange mutagenesis. Fol-
lowing the allelic exchange procedures, PCR
analysis revealed that 6 of 24 colonies exhibited
the deleted sub1154 locus. This was subse-
quently conﬁrmed by southern analysis (data
not shown). One such clone was stored and
used throughout this study as the Dsub1154
mutant strain. Sequence analysis of the deleted
locus also identiﬁed a single base pair deletion
116 bp beyond the ATG start codon. This addi-
tional frameshift event had the effect of prema-
turely terminating the theoretical deleted
translation product to just 55 amino acids, some
22 residues beyond the putative signal peptide
cleavage point.
3.4. Screening of mutants lacking SrtA
substrates for virulence/attenuation
Each mutant was used to challenge two
mammary quarters to determine if the inser-
tional mutation resulted in major attenuation
of S. uberis. In all cases, the bacteria recovered
post-challenge were genotyped by PCR and in
each case showed the presence of the correctly
mutated gene. In the case of isolates obtained
from contemporaneous challenges with the wild
type strain, a similar procedure showed the
presence of appropriate wild-type alleles (data
not shown).
Challenge with mutants carrying insertions
within sub0135, sub207, sub0241, sub0826,
sub1370 or sub1730 had little if any effect on
virulence and each strain induced moderate to
severe clinical signs of mastitis (data not
shown). In contrast, strains lacking any of
sub0145, sub0888, sub1095 or sub1154
showed few, if any, overt signs of infection dur-
ing the initial screening in two mammary quar-
ters. Subsequent rescreening, in a further two
mammary quarters, conﬁrmed the attenuation
in strains lacking sub0145, sub1095 or
sub1154 (Fig. 3C). However, in this instance
the strain lacking sub0888 colonised to high
levels. In contemporaneous challenges with
the wild type strain all quarters became colon-
ised at high levels (typically 10
5–10
7)a n dm o d -
erate to severe signs of mastitis were noted in
all six challenged quarters (Fig. 3C). All ani-
mals challenged with the wild type strain
required intervention with antibiotic therapy
by the ﬁfth milking post challenge.
The mutant lacking sub1095 appeared to
colonise in a manner similar to the wild-type
strain for 24 h, after which the numbers of the
mutant strain declined (Fig. 3A). In one animal,
bacterial colonisation fell below the level of
detection in both challenged quarters by 7 mil-
kings post challenge. The mutants lacking
either sub0145 or sub1154 showed impaired
colonisation compared to the wild type strain
(Fig. 3A). In marked contrast to the wild type,
colonisation with the mutant lacking sub1154
declined to the point where it was not detected
in any challenged quarter by the sixth milking
after challenge. However in both animals chal-
lenged with this strain, bacteria were subse-
quently re-isolated from one of the two
challenged quarters at milking 7. The mutant
lacking sub0145 showed reduced colonisation
throughout the experimental period and was
consistently re-isolated at levels 100 to 1000-
fold less than the wild type strain (Fig. 3A).
An inﬂux of somatic cells was evident in all
mammary quarters challenged with S. uberis;
the magnitude of the response was similar in
animals challenged with wild type or the
mutants lacking either sub0145 or sub1095.
However, the speed of the cellular response to
infection with the mutant strains was slower
than that to the wild-type. The speed and mag-
nitude of the cellular response to challenge with
the strain lacking sub1154 was markedly
reduced compared to that detected following
challenge with the wild type strain (Fig. 3B).
4. DISCUSSION
A homologue of srtA detected within
S. uberis 0140J (sub0881) was shown during
this investigation to be required for the full
expression of virulence by this bacterium. This
ﬁnding correlates with studies on other strepto-
cocci associated with different diseases that
have revealed the essential nature of SrtA activ-
ity. In the cases of S. pyogenes [5], S. sanguinis
[46], S. agalactiae [25]a n dS. gordonii [6]
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Page 10 of 16 (page number not for citation purpose)Figure 3. Bacterial isolation, somatic cell count and clinical response following challenge with S. uberis
0140J and mutants lacking individual SrtA- anchored proteins in dairy cattle. (A) Bacterial recovery of
S. uberis at each milking following challenge. Data are represented as the geometric means of the number of
bacteria obtained from the milk of animals challenged with either strain 0140J (n = 6) or the individual
SrtA-anchored protein mutants (sub1095 n = 4; sub1154 n = 4; sub0145 n = 4), as indicated on the ﬁgure.
(B) Cellular inﬂux at each milking following challenge. Data are represented by the geometric means of the
number of somatic cells obtained from the milk of animals challenged with either strain 0140J (n =6 )o rt h e
individual SrtA-anchored protein mutants (sub1095 n = 4; sub1154 n = 4; sub0145 n = 4), as indicated on
the ﬁgure. (C) Combined clinical scores at each milking following challenge. Data are represented by the
mean of the combined clinical scores given for the appearance of the quarter and appearance of the milk, as
outlined in Table II with either strain 0140J (n = 6) or the individual SrtA-anchored protein mutants
(sub1095 n = 4; sub1154 n = 4; sub0145 n = 4), as indicated on the ﬁgure.
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markedly decreased in strains where SrtA was
either defective or absent. In some of these
instances the altered phenotype, initially attrib-
uted to the absence of SrtA, was subsequently
shown to be directly linked to one or more sor-
tase anchored proteins [24, 46].
The SrtA isogenic mutant of S. uberis strain
0140J was isolated with an inserted ISS1 ele-
ment disrupting the gene between 248 bp and
249 bp of the nucleotide sequence, resulting
in a theoretically translated product that did
not code for any of the predicted active site of
the SrtA enzyme [14]. In line with the predicted
location for SrtA, this protein was only detected
in the cell membrane and cytoplasmic fractions
of wild type S. uberis and was not apparent in
any fractions from the isogenic mutant
(Fig. 1). A previous comparative proteomic
analysis revealed the requirement for sortase
to anchor proteins bearing the LPXTG or
LPXXXD motif at the surface of S. uberis [14].
Although initially able to colonise the
bovine mammary gland similarly to the wild-
type S. uberis, the mutant lacking SrtA was
unable to colonise the gland to high levels; with
bacterial numbers remaining approximately
1000-fold lower than those detected in milk
from animals challenged with the wild type
strain. This corresponded with the failure of
the srtA mutant to induce progressive clinical
signs of disease. Thus it was postulated that
anchoring of proteins by SrtA was required
for high level colonisation and/or induction of
severe inﬂammatory reactions associated with
clinical disease. As this mutant strain grew at
a rate and to a ﬁnal yield similar to that of the
wild type strain in both laboratory media and
skimmed milk from healthy, uninfected mam-
mary glands
1 interactions by SrtA anchored
proteins were considered to be speciﬁc to dis-
ease pathogenesis.
An increase in the somatic cell count (SCC)
is an indicator commonly used as a surrogate of
bacterial infection of the mammary gland and
mastitis. The inﬂammatory response to intra-
mammary bacterial infection results in a mas-
sive inﬂux of circulating polymorphonuclear
neutrophils (PMN) into the mammary tissue
and secretion. As in the situation during the cur-
rent investigation, the SCC can reach in excess
of 5 million cells/mL; over 90% of which are
PMN [31, 35]. The presence of such high num-
bers of leukocytes in milk usually coincides
with the onset of clinical signs of disease fol-
lowing challenge with a variety of mammary
pathogens including E. coli [18], S. aureus
[18, 38]a n dS. uberis [15, 16, 20, 26]. In this
study, following challenge with the wild-type,
SCC rose to between 10
6 and 10
7/mL by 4 mil-
kings (2 days) post challenge and severe clini-
cal signs of disease were detected in all
quarters by ﬁve milkings post challenge. How-
ever, although challenge with the srtA mutant
resulted in an increase in the SCC at a similar
speed and magnitude in response to challenge
with wild-type S. uberis, there was little or no
evidence of clinical signs of disease in these
animals. These data therefore uncouple the
response that stimulates inﬂux of inﬂammatory
cells from the responses that induce the inﬂam-
matory changes leading to overt signs of dis-
ease and imply that such signs are dependent
on the interplay between pathogen and host
during the process of infection.
Mutants lacking proteins identiﬁed previ-
ously to be anchored by SrtA (14) and one fur-
ther protein (sub0241) that was shown to
conform to that expected of a SrtA substrate
were isolated. In each case, the position of the
insertional element (ISS1) was such that disrup-
tion of the function of any residual gene product
was predicted. The bank did not contain a
mutant with a suitable lesion within sub1154;
although a mutant with an insertion near to
the end of this CDS was detected. This mutant
produced a large C-terminally truncated poly-
peptide likely to contain the serine-protease
active site domain. It is of note that the trun-
cated protein was predicted to lack the C-termi-
nal cell wall anchor (sorting domain) and that
this protein, unlike the full length protein in
the wild type, was not anchored at the bacterial
surface
1. Consequently, a mutant carrying a
deletion of sub1154 was produced by allelic
exchange mutagenesis.
Three of the mutant strains failed to induce
clinically apparent mastitis in any of four
1 Leigh J.A., et al., unpublished results.
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wild type strain that in contemporary challenges
induced mastitis in all six cases. This challenge
model using strain 0140J has proven to be very
reproducible and has been conducted on numer-
ous occasions by different research groups
around the world [4, 21, 29]. In each case, dis-
ease was evident in approximately 90% of the
quarters challenged and in no instance has there
been any report of an animal within a study that
has resisted challenge in two mammary quar-
ters. Therefore, the absence of clinical signs in
4 of 4 challenged mammary quarters would
strongly indicate that each of sub0145,
sub1095 and sub1154 play an important, inde-
pendent, non-redundant role in the pathogenesis
of mastitis due to S. uberis. It is possible that
other SrtA-anchored proteins also play a role
in pathogenesis but that any effect is masked
by the presence of another protein/activity that
is sufﬁcient to complement that missing from
the mutant.
It is also worthy of note that 2 of the 3 indi-
vidual mutant strains, lacking sub0145 or
sub1154, appeared less able to colonise the
bovine mammary gland than that lacking
sub0881 (srtA). This probably reﬂects the com-
plete absence of the target protein in these
strains. However, like the SrtA mutant, these
strains grew at a rate and to a ﬁnal yield similar
to that of the wild type strain in Todd Hewitt
broth and skimmed bovine milk from healthy
uninfected mammary glands
1.
In the srtA mutant, the proteins are likely to
be produced but not anchored to the bacterial
cell. Therefore, we can conclude that in addition
to the requirement of sub0145, sub1095 and/or
sub1154 for full expression of virulence there
may also be a requirement for the bacterium
to hold any or all of these, and or other SrtA-
anchored proteins, in close proximity to the
cell.
A number of the putative sortase substrate
proteins have been identiﬁed as virulence deter-
minants in other streptococcal species. The pro-
tein encoded by sub1154 shows 34% identity at
the protein level (BLASTP) to the C5a pepti-
dase of S. pyogenes. In Lanceﬁeld group A
and B streptococci this protein acts as a highly
speciﬁc serine peptidase and is also found on
the bacterial surface [11, 45]. The C5a pepti-
dase cleaves the C5a complement factor, which
is involved in the recruitment and activation of
phagocytic cells to the site of infection [23].
The equivalent protein in Group B Streptococ-
cus has also been shown to interact with ﬁbro-
nectin [42] and has been shown to have a role
during invasion of human epithelial cells in
culture [10].
The S. uberis protein sub1095 shows 46%
protein sequence identity to SclB of S. pyoge-
nes. SclB has been shown to be involved in
adhesion to ﬁbroblasts [37] and can bind host
Thrombin-activatable ﬁbrinolysis Inhibitor,
w h i c hi sp o s t u l a t e dt ob eu t i l i s e db yt h eb a c t e -
rium to modulate the host response to infection
[32]. A collagen-like protein in S. pneumoniae
was shown to have a role in invasion of host
cells in vitro but was not essential for virulence
[34]a n di nS. pyogenes a collagen like protein
was shown to mediate adherence and internali-
sation via the alpha(2)beta(1) integrin [8]. The
requirement for adherence and internalisation
during the pathogenesis of bovine mastitis has
not been demonstrated in vivo, but evidence
put forward from in vitro studies would indicate
that adherence and internalisation to a mam-
mary cell line (Mac-T) is largely dependent
on Sua, a protein found non-covalently associ-
ated with the cell surface [1].
The protein encoded by sub0145 has previ-
ously been identiﬁed as a possible virulence
determinant of S. uberis and at least one allelic
variant has been shown to bind bovine lactofer-
rin [28]. The concentration of this iron-chelat-
ing compound increases in the mammary
gland during infection [17] however whilst iron
limitation is known to have an anti-microbial
effect on some bacteria, it appears to have little
effect on the growth of S. uberis [9, 36]. How-
ever, lactoferrin can also bind other divalent
metal ions such as Mn [3, 41]. S. uberis has a
requirement for this metal ion in vivo and in
the absence of a high afﬁnity Mn uptake system
was unable to colonise the bovine mammary
gland [40].
In conclusion, the failure of a SrtA deﬁcient
strain of S. uberis to cause clinical mastitis in
dairy cattle indicates that a number of SrtA-
anchored proteins are likely to be involved in
S. uberis mastitis sortase anchored proteins Vet. Res. (2010) 41:63
(page number not for citation purpose) Page 13 of 16the pathogenesis of this bacterium. Further
investigation revealed that the list of proteins
involved includes sub0145, sub1095 and
sub1154, however their precise role in patho-
genesis is yet to be established.
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